Studies in many countries have documented reductions of acute myocardial infarction (AMI) hospitalizations with smokefree policies. However, evidence on the association of cigarette tax with AMI events is unclear. There have been no studies of the associations between these two policies and AMI hospitalizations in Thailand.
We used negative binomial time series analyses of AMI hospitalizations (ICD-10 codes I21.0-I21.9), stratified by sex and age groups, from October 2006 to September 2017 to determine whether there was a change in AMI hospitalizations as a result of the changes in cigarette prices and the implementation of a 100% smokefree law.
Cigarette price increases were associated with a significant 4.7% drop in AMI hospitalizations among adults younger than 45 (incidence rate ratio [IRR], 0.953; 95% confidence interval [CI], 0.914–0.993; p = 0.021). Implementation of the 100% smokefree law was followed by a significant 13.1% drop in AMI hospitalizations among adults younger than 45 (IRR, 0.869; 95% CI, 0.801–0.993; P = 0.001). There were not significant associations in older age groups.
The Thai cigarette tax policy and the smokefree law were associated with reduced AMI hospitalizations among younger adults. To improve effectiveness of the policies, taxes should be high enough to increase cigarette price above inflation rates, making cigarettes less likely to be purchased; smokefree laws should be strictly enforced.
Citation: Patanavanich R, Glantz SA (2020) Association between tobacco control policies and hospital admissions for acute myocardial infarction in Thailand, 2006-2017: A time series analysis. PLoS ONE 15(12): e0242570. https://doi.org/10.1371/journal.pone.0242570
Editor: Guillermo Paraje, Universidad Adolfo Ibanez, CHILE
Received: April 30, 2020; Accepted: November 4, 2020; Published: December 2, 2020
Copyright: © 2020 Patanavanich, Glantz. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All data used to prepare this paper are available from the cited sources. The Universal Health Coverage Scheme hospitalization database is not publicly available. Access to data can be requested directly from the National Health Security Office, Thailand. For further inquiries, please contact the Bureau of Health Information and Outcome Evaluation, National Health Security Office at 120 Thung Song Hong, Lak Si, Bangkok, Thailand 10210, or call 662-141-4000.
Funding: This work was supported by supported by National Institute of Drug Abuse grant R01DA043950 (SAG) and the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand (RP). The funding agencies played no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit for publication.
Competing interests: The authors have declared that no competing interests exist.
Cigarette smoking is a major risk factor of cardiovascular diseases (CVD) , with one of every three deaths from CVD attributable to smoking . In Thailand, smoking causes nearly 250,000 hospitalizations for CVD and costs 10 billion THB (US$342 million) annually . Cigarette smoking is also the most common risk factor of acute myocardial infarction (AMI) in patients younger than 45 years [4, 5]. Up to 92% of adults less than 45 years old with AMI are smokers, compared with only 40% of older patients [4, 6]. Smoking is also a predictor of coronary plaque rupture, particularly in young smokers [7, 8].
The World Health Organization (WHO) has recommended four evidence-based “best buy” interventions for tobacco use to reduce the economic impact of diseases caused by smoking, including tax increases, smokefree indoor workplaces and public places, health information and warnings, and bans on tobacco advertising, promotion, and sponsorship . Thailand ratified the WHO Framework Convention on Tobacco Control (FCTC) in 2004 and since then has strengthened it tobacco control policies . In 2019, WHO recognized Thailand’s high level of achievement in two of the best buy interventions: health warnings (since 2005) and smokefree policies (since 2010) .
Increasing cigarette taxes is an important intervention for reducing smoking prevalence [12–14], including in Thailand . Thailand has increased its cigarette excise tax gradually since allowing imported cigarettes in 1991 . The cigarette excise tax in Thailand increased from 55% to 90% of the ex-factory price (the price the manufacturer charges distributors) between 1992 and 2017. Driven at least in part by the increasing taxes, the price of a 20-cigarette pack of the most popular Thai brand (Krongthip) increased from 35 THB (US$1.1) in 1992 to 90 THB (US$2.8) in 2017 [17, 18] and smoking prevalence dropped from 32% in 1991 to 19% in 2017 .
The effects of smokefree laws on reducing AMI hospitalization have been well-documented, particularly among people younger than 65 years, in developed countries such as the U.S. and European countries . Thailand began implementing smoking restrictions in 1992 and then repeatedly updated them to expand smokefree places . In 2010, Thailand achieved 100% smokefree public places at the highest level of FCTC Article 8 (Protection of people from tobacco smoke) .
The ultimate goal of tobacco control policies is not to reduce smoking but to reduce the burden of disease and death caused by tobacco use. Numerous studies demonstrate the association of smokefree law implementation with the reduction of CVD morbidity and mortality . However, evidence on the effects of cigarette tax on CVD events is limited . A study in the U.S. found that an increase in the cigarette tax is associated with a significant decline in age-adjusted AMI hospitalization rates among men , but there are not yet studies in less-developed countries. To our knowledge, there are no studies in Thailand estimating the effects of raising cigarette excise taxes and smokefree policies on CVD events.
This study used negative binomial time series regressions to examine the statistical association between cigarette price increases (as the cigarette tax increased) and the strengthening the smokefree law from a partial ban to a 100% smokefree indoor workplaces and public places rule in 2010 [23–25] and AMI hospitalizations in Thailand between October 2006 and September 2017 and whether these associations varied across age and sex groups.
We used the de-identified inpatient discharge data from the Universal Health Coverage Scheme, the largest public health insurance program in Thailand, which covers 75% of the Thai population [26, 27]. AMI was defined as a primary discharge diagnosis with International Classification of Disease version 10 (ICD-10) diagnostic codes I21.0-I21.9 . These diagnostic codes include both ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI). The monthly AMI hospitalizations were calculated from October 2006 to September 2017 (a total of 132 months) and stratified by sex and age groups (18–44, 45–59, and 60 years and over).
Data on cigarette prices were retrieved from the announcements of the Thai Excise Department and Revenue Department on the Royal Thai Government Gazette . Market shares of cigarettes by brands were based on Excise Department data on the monthly taxed volume of cigarette packs by brand from October 2006 to September 2017 provided by the Action for Smoking and Health Foundation Thailand. Monthly average cigarette prices were translated into real THB as of September 2007 using the national consumer price index from the reports of the Thai Ministry of Commerce .
We employed negative binomial time series regressions to analyze the 132-months of data from October 2006 through September 2017. (The data on the market share of cigarettes by brand from the Excise Department are only available through September 2017.) The dependent variable was number of monthly AMI hospitalizations, stratified on the sex and age (in separate analyses). The independent variables were the average cigarette price weighted by market share (in 10 THB) and a dummy variable to indicate the change of the smokefree policy, assigning 1 from June 2010 and 0 before that.
We controlled for the total monthly all-cause hospital admissions to account for the trend of monthly hospital uses . We included dummy variables for month to allow for seasonal variation.
We also included a continuous time variable to allow for underlying secular trend (1 beginning on October 2006 and 132 on September 2017) and time squared (mean-centered) to allow for nonlinear effects in time. We included the quadratic term because in preliminary analysis (likelihood ratio tests and comparing R2) showed that including the quadratic time trend significantly improved the fit to the data .
Correlograms of the residuals revealed statistically significant autocorrelations in the residuals for the fit among all sex and age-specific outcomes except among men and women age 18–44. Therefore, we added a one-month lag of AMI hospitalizations as an independent variable to all the regression models (including the model for men and women ages 18–44 for consistency). Adding the lagged independent variable reduced all the autocorrelations to nearly zero and nowhere near significant (first lag autocorrelation for AMI among total population, 0.093; second, 0.021; and third, -0.004, with p-values 0.282, 0.544 and 0.748, respectively; results were similar for sex and age-specific outcomes). The lagged independent variables did not substantially affect the parameter estimates for the price and smokefree variables.
We analyzed the data using Stata 14 using the command nbreg AMI CigPrice SmokeFree TotalAdmission i.MONTH TIME TIME2 l.AMI, irr to estimate the predictive association for number of AMIs per month as a function of the independent variables described above. i.MONTH creates a set of dummy variables for the different months and l.AMI adds AMI’s lagged by 1 month as an independent variable. irr reports results as incident rate ratios. The Stata documentation  provides more details on how the nbreg command relates to negative binomial model.
We also did the same analysis using a Poisson regression, which makes more assumptions about the data structure than negative binomial regression.
Ethics approval was not required because this study used deidentified data.
During the study period there were four cigarette excise taxes increases: September 2007 (from 79% to 80% as a percentage of the ex-factory price) , May 2009 (from 80% to 85%) , August 2012 (from 85% to 87%) , and February 2016 (from 87% to 90%) . We determined the weighted average cigarette prices based on different brand prices of the five most-sold brands in Thailand (Krongthip, Wonder, SMS, L&M, and Marlboro) and their monthly market shares. These five brands comprised over 90% of the total Thai market .
Dots are average cigarette price for each month. Vertical solid lines indicate the change in cigarette tax rates. The vertical dash line indicates implementation of Thailand’s 100% smokefree law. New low-priced cigarette brands and slim cigarettes introduced in 2010, made average cigarette prices in Thailand remain relatively unchanged or even lower during 2009–2016.
As of October 2006, the smoking restriction law prohibited smoking in indoor air-conditioned places only [23, 24]. In June 2010, a 100% smokefree law was implemented that required all indoor public and work places and other open-air public places such as restaurants and markets to be smokefree  (Table 1).
This was a substantial change because non air-conditioned restaurants and markets were more common in 2005 and only 33% of Thai people went to air-conditioned restaurants regularly .
Associations of cigarette prices and smokefree laws on AMI
A total of 435,208 AMIs occurred between October 2006 and September 2017 in Thailand, 249,615 (57%) were males and 185,593 (43%) were females. Mean ages were 66 years; 64 years for males and 68 years for females. Average monthly AMI hospitalizations were 3,297. The proportions of AMI among age groups were 4.9% for age 18–44, 24.3% for age 45–59, and 68.2% for age 60 and older.
We found cigarette price increases and the smokefree laws were significantly associated with reduction of AMI hospitalizations among adults younger than 45 years, but not other age groups (Table 2). Cigarette price increases were associated with a significant 4.7% drop in AMI hospitalizations per 10 THB increase (incidence rate ratio [IRR], 0.953; 95% confidence interval [CI], 0.914–0.993; p = 0.021). Among 18–44 year olds, the point estimates were similar in men (IRR 0.948) and women (IRR 0.943), but the association was only statistically significant among men (Table 3).
The implementation of the 100% smokefree law was followed by a significant 13.1% drop in AMI hospitalizations among adults aged 18–44 years (IRR, 0.869; 95% CI, 0.801–0.993; p = 0.001); the significant reduction of AMI hospitalizations among this age group was similar and significant in both sexes (Table 3).
The sensitivity analysis conducted with a Poisson regression (S1 Table) produced similar results as the main analysis using negative binomial regression (Table 2), except that the Poisson analysis showed smokefree laws associated with significantly more AMIs among people 60 years old and older. This unusual result may be due to the fact that the Poisson regression makes more assumptions about the underlying data structure than negative binomial regression.
This study highlighted the associations between raising cigarette prices and the implementation of a smokefree law on improving health. These two policies are population-based interventions to prevent smoking initiation, induce smokers to quit or reduce their cigarette consumption, and decrease exposure to secondhand smoke among non-smokers .
Several studies have indicated that smoking is the most common risk factor for AMI in young adults under age 45 [4, 6]. Our study demonstrates an association between increased cigarette prices and reduced AMI hospitalizations among this age group. This result is consistent with findings that younger adults were more responsive to changes in cigarette prices through increased taxes than older adults [12–14, 43]. Our finding that the significant associations with raising cigarette taxes were limited to males may reflect two factors. First, the number of male smokers under age 45 was 36 times higher than female smokers, and this difference declines with age . Second, previous studies found AMI in young adults occurred 3 times more often in men than in women and heart disease developed 7 to 10 years later in women than in men [4, 45]. Similarly, our data showed the number of AMI hospitalizations was 3 times higher in men than in women at the age of 18–44 and the difference was smaller among older age groups. The fact that the point estimates were similar among men and women age 18–44 year olds (Table 3) suggests that the failure to reach statistical significance for the women may be due to the smaller number of AMIs among women.
The point estimates associated with raising cigarette prices on AMI hospitalizations were less than we expected. We did not find significant associations effects among the total population as observed in some other countries . It could be the tax increases were not always followed by increase in cigarette prices because of industry price manipulation to buffer the price effect .
Consistent with previous studies , the implementation of the comprehensive smokefree law in Thailand was associated with a significant drop in AMI hospitalizations among young adults aged 18–44 years. The point estimate for the association of smokefree law on AMI hospitalizations was substantial, equivalent to about a 30 THB increase in price. It took about 10 years in Thailand to have a 30 THB increase in cigarette prices (the average cigarette price was 39 THB in 2006 did not increase to 67 THB until 2017). Many studies have also found that smoking bans have a greater effect on AMI occurrence among younger compared to older patients [48–51]. Other studies have shown that smoking bans have a greater effect on AMI hospitalizations among non-smokers compared to smokers due to reductions of secondhand smoke [52, 53]. Youth and young adults are exposed to higher rates of secondhand smoke than older adults, consistent with growing evidence that comprehensive smokefree laws contribute to a greater decrease in passive smoking than active smoking [48, 50, 52–54].
We did not see a significant drop in AMI hospitalizations in adults older than 45 years following the comprehensive smokefree law in Thailand. This could be due to ineffective law enforcement and compliance. The 2016 stakeholder’s assessment of Thailand’s compliance with the WHO FCTC Article 8 revealed that the level of implementation rated for effectiveness was low, especially the enforcement and public understanding of smokefree principles . This assessment was consistent with the 2017 national smoking and drinking behavior survey data that showed a significant proportion of people experienced secondhand smoke in public places, especially marketplaces (74.5%), public transportation (68.2%), and restaurants (64.2%) .
Our findings indicated that if the price per pack of cigarettes increased by 10 THB, the number of AMI hospitalizations could be reduced by 4.7% among adults younger than 45 or save approximately 91 patients from having AMI annually (from our data, average monthly AMI hospitalizations among adults younger than 45 was 161). Additionally, the smokefree law could reduce the number of AMI hospitalizations by 13.1% among adults younger than 45 or save approximately 254 patients from having AMI annually. A previous study in Thailand showed an average hospital admission cost for a CVD patient was 43,000 THB (US$1,390) . Thus, every 10 THB increase in the sale price of a pack of cigarette combined with implementation of the smokefree law could save approximately 345 AMI patients or 14.8 million THB (US$479,550) in hospital admission costs due to AMI annually. However, the direct medical cost for inpatient treatments only accounts for 9% of all costs attributable to smoking . If other costs such as the direct medical cost for outpatient visits, indirect medical cost for transportation, out-of-pocket, and non-medical cost for loss of income for patients and caregivers and due to death were considered, preventing 345 patients from having AMI could save approximately 164.8 million THB (US$5.3 million).
The combined magnitude of the associations between price increases and smokefree law were substantial among 18–44 year olds. Between June 2010 and September 2017, the number of AMIs in this group were 3,190 below what would have been predicted absent these changes (Fig 2), accounting for a savings of at least 137 million THB (US $4.4 million) in direct health costs, which increased to 1.52 billion THB (US $49.2 million) when including the indirect health costs. The comparison of the rates of AMI hospitalizations by age groups had there been no price changes and no 100% smokefree law is shown in Table 4.
The number of AMI hospitalizations among age 18–44 dropped significantly after the increase in cigarette price and the implementation of 100% smokefree law between October 2006 and September 2017. Solid lines (blue) on the plots are the predicted number of AMI hospitalizations per month from the negative binomial regression model. Dots are the number of AMI hospitalizations each month. Dashed lines (red) on the plots are the predicted numbers of AMI hospitalizations had there been no price changes and no 100% smokefree law. The ups and downs in the regression lines represent seasonal (monthly) variation in the number of AMI hospitalizations. Dash vertical lines indicate when the cigarette tax increased and a solid vertical line indicate when the 100% smokefree law was implemented.
There are several limitations of this study. This study is an ecological study in which we do not have detailed information about individual patients, including their smoking status, so it is not possible to differentiate between events related to smoking or passive smoking. The study is based on hospitalization data, it could be possible that diagnosis coding was wrongly assigned and that there were variations in coding practice among hospitals . Also, people under the Universal Health Coverage Scheme tend to have low socioeconomic status; therefore, our findings may not be generalized to people under other health insurance programs .
This study did not account for untaxed tobacco products such as hand-rolled cigarettes, which is a substitute for manufactured cigarettes in Thailand . We did not explicitly consider any changes in air pollution such as PM2.5 due to the unavailability of the dataset for the entire country . We did not include the health warning policy because Thai tobacco products have been compliant with the WHO FCTC’s health warning provisions since 2005 and the bans on tobacco advertising and promotion did not change during our study period [59, 60]. We did, however, include variables to account for seasonal variation and a secular trend to assume air pollution had not remained in a steady state throughout the period of the study.
Lastly, because cigarette excise tax policy in Thailand was changed in October 2017 from the ex-factory price to the retail selling price and from a one-tier to a two-tier ad valorem excise system with a minimum specific excise floor tax, we limited our analysis to prior this tax policy change .
These findings support implementation of tobacco control policies in Thailand such as raising cigarette prices through increasing cigarette taxes and implementing the smokefree law. These laws not only decreased cigarette smoking prevalence, but also reduced smoking-caused diseases, notably AMI hospitalizations. To maintain effectiveness of tobacco control policies, the government should be wary of deceptive tobacco industry tactics that undermine the cigarette tax policy and should strengthen law enforcement of smokefree policies. Our results also suggest that improving implementation and enforcement of the smokefree law would further reduce AMI hospitalizations.
S1 Table. Association between tobacco control policies and AMI hospitalizations stratified on age (Poisson regression analysis).
- 1. National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.
- 2. Centers for Disease Control and Prevention. Smoking and Heart Disease and Stroke 2019 [updated January 28, 2019; cited 2020 January 14]. https://www.cdc.gov/tobacco/campaign/tips/diseases/heart-disease-stroke.html.
- 3. Patanavanich R, Aekplakorn W, Suriyawongpaisal P. Trend analysis of smoking-attributable hospitalizations in Thailand, 2007–2014. Tob Induc Dis. 2018;16:52. Epub 2019/09/14. pmid:31516449.
- 4. Egred M, Viswanathan G, Davis GK. Myocardial infarction in young adults. Postgrad Med J. 2005;81(962):741–5. Epub 2005/12/14. pmid:16344295.
- 5. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 1995;26(3):654–61. Epub 1995/09/01. pmid:7642855.
- 6. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med. 1999;107(3):254–61. Epub 1999/09/24. pmid:10492319.
- 7. Hou F, Zhou Y, Liu W, Yang S, Wang Z, Ma X, et al. Characteristics of culprit lesions in young patients with metabolic syndrome and classic cardiovascular risk factors. Exp Ther Med. 2020;19(4):2766–72. Epub 2020/04/08. pmid:32256759.
- 8. Iannaccone M, Quadri G, Taha S, D’Ascenzo F, Montefusco A, Omede P, et al. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2016;17(10):1128–37. Epub 2015/10/29. pmid:26508517.
- 9. World Health Organization. From Burden to “Best Buys”:Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries Geneva, Switzerland2011 [cited 2020 January 15]. https://www.who.int/nmh/publications/best_buys_summary.pdf.
- 10. Charoenca N, Kungskulniti N, Sritabutra D, Pitayarangsarit S, Hamann SL. Using an Assessment Tool to Further Tobacco Control Accomplishment in Thailand. Tob Use Insights. 2018;11:1179173X18759945. Epub 2018/03/14. pmid:29531475.
- 11. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019 Geneva, Switzerland2019 [March 3, 2020]. https://apps.who.int/iris/bitstream/handle/10665/326043/9789241516204-eng.pdf?ua=1.
- 12. Ding A. Youth are more sensitive to price changes in cigarettes than adults. Yale J Biol Med. 2003;76(3):115–24. Epub 2004/09/17. pmid:15369626.
- 13. Chaloupka FJ. Macro-social influences: The effects of prices and tobacco-control policies on the demand for tobacco products. Nicotine & Tobacco Research. 1999;1(Suppl_1):S105–S9. pmid:11072413
- 14. Chaloupka FJ, Wechsler H. Price, tobacco control policies and smoking among young adults. Journal of Health Economics. 1997;16(3):359–73. https://doi.org/10.1016/s0167-6296(96)00530-9 pmid:10169306
- 15. Levy DT, Benjakul S, Ross H, Ritthiphakdee B. The role of tobacco control policies in reducing smoking and deaths in a middle income nation: results from the Thailand SimSmoke simulation model. Tob Control. 2008;17(1):53–9. Epub 2008/01/26. pmid:18218810.
- 16. Vateesatokit P, Hughes B, Ritthphakdee B. Thailand: winning battles, but the war’s far from over. Tobacco Control. 2000;9(2):122. pmid:10841840
- 17. World Bank Group. Economics of Tobacco Taxation Toolkit 2018 [updated March 2018; cited 2020 March 16]. http://documents.worldbank.org/curated/en/238861522243274209/Economics-of-Tobacco-Taxation-Toolkit.
- 18. WorldData.info. Development of inflation rates in Thailand 2020 [cited 2020 February 19]. https://www.worlddata.info/asia/thailand/inflation-rates.php.
- 19. Pitayarangsarit S, Pankrajang P. Statistics report on tobacco consumption in Thailand, 2018 [in Thai] Bangkok, Thailand2018 [cited 2020 March 16]. http://www.trc.or.th/th/media/attachments/2562/01/29/2561.pdf.
- 20. Kungskulniti N, Pitayarangsarit S, Hamann SL. Stakeholder’s Assessment of the Awareness and Effectiveness of Smoke-free Law in Thailand. Int J Health Policy Manag. 2018;7(10):919–22. Epub 2018/10/15. pmid:30316244.
- 21. Liu E, Rivers PA, Sarvela PD. Does increasing cigarette excise tax improve people’s health? The cases of heart attacks and stroke. J Health Care Finance. 2008;34(3):91–109. Epub 2008/05/13. pmid:18468381.
- 22. Ma ZQ, Kuller LH, Fisher MA, Ostroff SM. Use of interrupted time-series method to evaluate the impact of cigarette excise tax increases in Pennsylvania, 2000–2009. Prev Chronic Dis. 2013;10:E169. Epub 2013/10/19. pmid:24135393.
- 23. World Health Organization. WHO report on the global tobacco epidemic, 2009: implementing smoke-free environments 2009 [March 3, 2020]. https://www.who.int/tobacco/mpower/2009/gtcr_download/en/.
- 24. Vathesatogkit P, Charoenca N. Tobacco control: lessons learnt in Thailand. Indian J Public Health. 2011;55(3):228–33. Epub 2011/11/18. pmid:22089691.
- 25. World Health Organization. WHO report on the global tobacco epidemic 2011: Warning about the dangers of tobacco Geneva, Switzerland2011 [March 3, 2020]. https://www.who.int/tobacco/global_report/2011/en/.
- 26. Limwattananon S, Tangcharoensathien V, Tisayaticom K, Boonyapaisarncharoen T, Prakongsai P. Why has the Universal Coverage Scheme in Thailand achieved a pro-poor public subsidy for health care? BMC Public Health. 2012;12(1):S6. pmid:22992431
- 27. Panpiemras J, Puttitanun T, Samphantharak K, Thampanishvong K. Impact of Universal Health Care Coverage on patient demand for health care services in Thailand. Health Policy. 2011;103(2–3):228–35. Epub 2011/09/21. pmid:21930324.
- 28. Sebrie EM, Sandoya E, Hyland A, Bianco E, Glantz SA, Cummings KM. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay. Tob Control. 2013;22(e1):e16–20. Epub 2012/02/18. pmid:22337557.
- 29. The Royal Thai Government Gazette. Government Gazette Search [in Thai] 2020 [cited 2020 February 19]. http://www.ratchakitcha.soc.go.th/RKJ/announce/search.jsp.
- 30. Ministry of Commerce. Consumer Price Index (CPI) 2019 [cited 2020 February 19]. http://www.price.moc.go.th/price/cpi/index_new_e.asp.
- 31. Weaver AM, Wang Y, Rupp K, Watson DP. Effects of smoke-free air law on acute myocardial infarction hospitalization in Indianapolis and Marion County, Indiana. BMC Public Health. 2018;18(1):232. Epub 2018/02/11. pmid:29426315.
- 32. Stimson JA, Carmines EG, Zeller RA. Interpreting Polynomial Regression. Sociological Methods & Research. 1978;6(4):515–24.
- 33. Stata.com. nbreg—Negative binomial regression [28 Oct 2020]. https://www.stata.com/manuals13/rnbreg.pdf.
- 34. White JS, Ross H. Smokers’ strategic responses to sin taxes: evidence from panel data in Thailand. Health Econ. 2015;24(2):127–41. Epub 2014/03/29. pmid:24677731.
- 35. Husain MJ, Kostova D, Mbulo L, Benjakul S, Kengganpanich M, Andes L. Changes in cigarette prices, affordability, and brand-tier consumption after a tobacco tax increase in Thailand: Evidence from the Global Adult Tobacco Surveys, 2009 and 2011. Prev Med. 2017;105S:S4–S9. Epub 2017/06/06. pmid:28579499.
- 36. Ratanachena S, Dorotheo U. Affordability of cigarettes and the impact of raising tobacco excise taxes in southeast asia: Cambodia, Indonesia, Lao PDR, Philippines, Thailand and Vietnam: Southeast Asia Tobacco Control Alliance; 2012 [March 6, 2020]. https://seatca.org/dmdocuments/Affordability-final-11-01-56-web.pdf.
- 37. Southeast Asia Tobacco Control Alliance. Asian tobacco tax report card: regional comparisons and trends 2016 [March 6, 2020]. https://seatca.org/dmdocuments/ASEANtaxReport2016.pdf.
- 38. Euromonitor International. Brand Shares: Cigarettes Thailand 2020 [cited 2020 March 16]. https://www.portal.euromonitor.com/portal/statisticsevolution/index.
- 39. Ministry of Public Health. Notification of the Ministry of Public Health (No. 19) B.E. 2553 (A.D. 2010): Re: Designating Names or Types of Public Places Where Non-Smoker’s Health is under Protection and Designating a Zone or All Area of Such Places to be a Smoking Area or a Non-Smoking Area Pursuant to the Non-Smoker’s Health Protection Act B.E. 2535 (A.D. 1992) Government Gazette2010.
- 40. Ministry of Public Health. Notification of the Ministry of Public Health (No. 17) B.E. 2549 (A.D. 2000): Re: Designating Names or Types of Public Places Where Non-Smoker’s Health is under Protection and Designating a Zone or All Area of Such Places to be a Smoking Area or a Non-Smoking Area Pursuant to the Non-Smoker’s Health Protection Act B.E. 2535 (A.D. 1992) Government Gazette 2006.
- 41. Yong HH, Foong K, Borland R, Omar M, Hamann S, Sirirassamee B, et al. Support for and reported compliance among smokers with smoke-free policies in air-conditioned hospitality venues in Malaysia and Thailand: findings from the International Tobacco Control Southeast Asia Survey. Asia Pac J Public Health. 2010;22(1):98–109. Epub 2009/12/25. pmid:20032039.
- 42. Krauss MJ, Cavazos-Rehg PA, Plunk AD, Bierut LJ, Grucza RA. Effects of state cigarette excise taxes and smoke-free air policies on state per capita alcohol consumption in the United States, 1980 to 2009. Alcohol Clin Exp Res. 2014;38(10):2630–8. Epub 2014/09/24. pmid:25257814.
- 43. Sarntisart I. An Economic Analysis of Tobacco Control in Thailand: The World Bank; 2003 [cited 2020 March 20, 2020]. http://documents.worldbank.org/curated/en/382721468760559277/pdf/289020Sarntisa1omic11Thailand1whole.pdf.
- 44. National Statistical Office. The Smoking and Drinking Behaviour Survey 2017. Bangkok, Thailand: Social Statistics Division, National Statistical Office, 2018.
- 45. Maas AHEM Appelman YEA. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598–602. pmid:21301622.
- 46. Jan C, Lee M, Roa R, Herrera V, Politis M, Motta J. The association of tobacco control policies and the risk of acute myocardial infarction using hospital admissions data. PloS one. 2014;9(2):e88784–e. pmid:24520421.
- 47. Apollonio DE, Glantz SA. Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents. Nicotine Tob Res. 2019. Epub 2019/05/07. pmid:31058282.
- 48. Barone-Adesi F, Gasparrini A, Vizzini L, Merletti F, Richiardi L. Effects of Italian smoking regulation on rates of hospital admission for acute coronary events: a country-wide study. PLoS One. 2011;6(3):e17419. Epub 2011/03/15. pmid:21399685.
- 49. Barone-Adesi F, Vizzini L, Merletti F, Richiardi L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J. 2006;27(20):2468–72. Epub 2006/08/31. pmid:16940340.
- 50. Mead EL, Cruz-Cano R, Bernat D, Whitsel L, Huang J, Sherwin C, et al. Association between Florida’s smoke-free policy and acute myocardial infarction by race: A time series analysis, 2000–2013. Prev Med. 2016;92:169–75. Epub 2016/10/30. pmid:27261406.
- 51. Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation. 2012;126(18):2177–83. Epub 2012/10/31. pmid:23109514.
- 52. Pell JP, Haw S, Cobbe S, Newby DE, Pell ACH, Fischbacher C, et al. Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome. New England Journal of Medicine. 2008;359(5):482–91. pmid:18669427.
- 53. Seo D-C, Torabi MR. Reduced Admissions for Acute Myocardial Infarction Associated with a Public Smoking Ban: Matched Controlled Study. Journal of Drug Education. 2007;37(3):217–26. pmid:18047180.
- 54. Twose J, Schiaffino A, Garcia M, Borras JM, Fernandez E. Correlates of exposure to second-hand smoke in an urban Mediterranean population. BMC Public Health. 2007;7:194. Epub 2007/08/09. pmid:17683585.
- 55. Patanavanich R. Data on Smoking Situation in Thailand at Provincial Level, 2001–2017 [in Thai]. Bangkok, Thailand: 2019.
- 56. Bundhamcharoen K, Aungkulanon S, Makka N, Shibuya K. Economic burden from smoking-related diseases in Thailand. Tob Control. 2016;25(5):532–7. Epub 2015/10/03. pmid:26427527.
- 57. Pongpirul K, Walker DG, Winch PJ, Robinson C. A qualitative study of DRG coding practice in hospitals under the Thai Universal Coverage Scheme. BMC Health Services Research. 2011;11(1):71. pmid:21477310
- 58. Pinichka C, Makka N, Sukkumnoed D, Chariyalertsak S, Inchai P, Bundhamcharoen K. Burden of disease attributed to ambient air pollution in Thailand: A GIS-based approach. PLoS One. 2017;12(12):e0189909. Epub 2017/12/22. pmid:29267319.
- 59. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package Geneva, Switzerland2008 [March 3, 2020]. https://apps.who.int/iris/bitstream/handle/10665/43818/9789241596282_eng.pdf?sequence=1.
- 60. World Health Organization. WHO report on the global tobacco epidemic, 2017: Monitoring tobacco use and prevention policies Geneva, Switzerland2017 [March 3, 2020]. https://apps.who.int/iris/bitstream/handle/10665/255874/9789241512824-eng.pdf?sequence=1&isAllowed=y.